SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets

被引:0
作者
Yue Li
Ashley Duche
Michael R. Sayer
Don Roosan
Farid G. Khalafalla
Rennolds S. Ostrom
Jennifer Totonchy
Moom R. Roosan
机构
[1] Chapman University,School of Pharmacy
[2] Western University of Health Sciences,College of Pharmacy
[3] California Health Sciences University,College of Pharmacy
来源
BMC Genomics | / 22卷
关键词
COVID-19; SARS-CoV-2 gene expression signature; Bronchoalveolar lavage fluid cells; Peripheral blood mononuclear cells; COVID-19 treatments;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 327 条
[1]  
Cavalli E(2020)Transcriptomic analysis of COVID-19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection Int J Mol Med 46 1266-1273
[2]  
Petralia M(2020)Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 —United States, January–February 2020 Clin Infect Dis 4 1-4
[3]  
Basile M(2020)Laboratory diagnosis of COVID-19: current issues and challenges J Clin Microbiol 58 1-9
[4]  
Bramanti A(2020)Detection of SARS - CoV - 2 in Different Types of Clinical Specimens JAMA 323 2762997-1207
[5]  
Bramanti P(2020)Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med 382 1199-1500
[6]  
Nicoletti F(2020)Care for Critically ill Patients with COVID-19 JAMA 323 1499-8
[7]  
Patel MR(2020)New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis BMC Med 18 1-280.e8
[8]  
Carroll D(2020)SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Cell 181 271-1072
[9]  
Ussery E(2020)ADAM17 inhibition may exert a protective effect on COVID-19 Nephrol Dial Transplant 35 1071-1034
[10]  
Whitham H(2020)COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 395 1033-1076